ARCHIVES

In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival

This article is from The Cancer Letter archive.

Vol. 07 No. 41 | October 9, 1981

Download PDF Visit The Full Archive

Related Articles

Compliance Grants Awarded, Contract Pending On Differences In Black/White Survival

November 19, 1982

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

FDA Approves Rituxan For CLL

February 19, 2010

Long-Term Results Find Cisplatin Improves Survival

May 25, 2007

Funding opportunities listed.

February 20, 2004

Bone Marrow Transplant Survival Has Doubled In Young Patients

August 26, 2011